Clinical Trial Update: Evaluation of the Phased Radio Frequency Ablation System [NA]

View source ↗

Summary

The trial evaluating the Phased Radio Frequency Ablation System for persistent atrial fibrillation has been terminated, with results posted in March 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Phased Radio Frequency Ablation System

Snippet

Sponsor: Medtronic Cardiac Ablation Solutions | Conditions: Persistent Atrial Fibrillation | NA | Status: TERMINATED | Results posted: 2018-03-22